# Chlorthalidone

Drug · id `cardio:chlorthalidone` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Thalitone; Chlortalidone

Browse, organ or system: Heart; Kidneys  
Browse, condition area: High blood pressure; Heart failure  

## In plain language

Chlorthalidone is a thiazide-like diuretic taken by mouth. The US label read, for Thalitone, lists two uses: the treatment of hypertension, to lower blood pressure, and, in adults, adjunctive therapy in edema associated with heart failure, cirrhosis of the liver, and renal disease, including nephrotic syndrome. Thalitone is one brand; other chlorthalidone tablets have their own labels, which were not read.

## Technical summary

RxNorm ingredient 2409; UNII Q0MQD1073Q. MeSH descriptor D002752 is Chlorthalidone. Class: Thiazide-like Diuretic (FDA established pharmacologic class, RxClass). The label read is the THALITONE (chlorthalidone) tablets, Casper Pharma LLC label, effective 2026-06-25 in openFDA (application NDA019574). Other chlorthalidone labels in openFDA, from other sponsors and repackagers, were not read. This page records label indications and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People for whom the US label of chlorthalidone (Thalitone) lists an indication: hypertension, edema (including edema of heart failure)

Recipient: Recipient not specified; Population: Patients described in the indications section of the label. Only the edema sentence says adults; the hypertension passage read does not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Only the edema sentence says adults; the hypertension passage read does not state an age range; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of THALITONE (chlorthalidone), in the Casper Pharma LLC version dated 2026-06-25 in openFDA, lists the medicine for the treatment of hypertension, to lower blood pressure, and, in adults, as adjunctive therapy in edema associated with heart failure, cirrhosis of the liver, and renal disease, including nephrotic syndrome.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients described in the indications section of the label. Only the edema sentence says adults; the hypertension passage read does not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Only the edema sentence says adults; the hypertension passage read does not state an age range; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-09
- Sources:
  1. Supports: openFDA drug label record for THALITONE (chlorthalidone) tablets, Casper Pharma LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id bc5a0299-115b-4e60-bb3f-c75a95c51c15 (manufacturer Casper Pharma LLC, application NDA019574), returned on 2026-11-09. The label text is dated 2026-06-25 (effective\_time). Other openFDA records of chlorthalidone labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22bc5a0299-115b-4e60-bb3f-c75a95c51c15%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-09T13:18:04Z. Source state: Current. Version fingerprint: b8ddb25b1964616c0cf70118ed5dcb0d5be237fbde35a857491f11293305ae5a.
     How it applies: The label sentences that give the indications named in the statement, each quoted in the research quote table.
  2. Background: openFDA drug label record for THALITONE (chlorthalidone) tablets, Casper Pharma LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id bc5a0299-115b-4e60-bb3f-c75a95c51c15 (manufacturer Casper Pharma LLC, application NDA019574), returned on 2026-11-09. The label text is dated 2026-06-25 (effective\_time). Other openFDA records of chlorthalidone labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22bc5a0299-115b-4e60-bb3f-c75a95c51c15%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:18:04Z. Source state: Current. Version fingerprint: b8ddb25b1964616c0cf70118ed5dcb0d5be237fbde35a857491f11293305ae5a.
     How it applies: Effective date of the label text read, 20260625.

## Connected pages

- Chlorthalidone is a thiazide-like diuretic (FDA established pharmacologic class in RxClass): Thiazide and thiazide-like diuretics (`cardio:thiazide-and-thiazide-like-diuretics`)
- FDA label lists hypertension as an indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-chlorthalidone-label-indications` and its context]
- FDA label lists adjunctive therapy, in adults, in edema associated with heart failure as an indication: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-chlorthalidone-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 8 registry products
- 5 registry trials

## Provenance

Content hash: 62ed722b4a7532805391080ba3b7e088911c4c70dc75b684940b0c30f22e8ed6
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
